SCM

Sio Capital Management Portfolio holdings

AUM $249M
1-Year Return 117.71%
This Quarter Return
+11.74%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$130M
AUM Growth
+$34M
Cap. Flow
+$21.8M
Cap. Flow %
16.76%
Top 10 Hldgs %
63.42%
Holding
63
New
18
Increased
8
Reduced
9
Closed
10

Top Buys

1
SNY icon
Sanofi
SNY
$12.2M
2
BIIB icon
Biogen
BIIB
$7.56M
3
PBYI icon
Puma Biotechnology
PBYI
$5.95M
4
TMO icon
Thermo Fisher Scientific
TMO
$4.61M
5
GSK icon
GSK
GSK
$3.4M

Top Sells

1
HRC
HILL-ROM HOLDINGS, INC.
HRC
$5.98M
2
EW icon
Edwards Lifesciences
EW
$5.15M
3
ZBH icon
Zimmer Biomet
ZBH
$4.82M
4
ACRS icon
Aclaris Therapeutics
ACRS
$3.76M
5
NTUS
Natus Medical Inc
NTUS
$3.16M

Sector Composition

1 Healthcare 88.21%
2 Industrials 4.3%
3 Financials 3.64%
4 Technology 0.95%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SYRE icon
26
Spyre Therapeutics
SYRE
$1.02B
$1.27M 0.71%
6,796
-743
-10% -$138K
VCRA
27
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1.24M 0.69%
+49,871
New +$1.24M
MZOR
28
DELISTED
Mazor Robotics Ltd.
MZOR
$937K 0.52%
+31,465
New +$937K
AVDL
29
Avadel Pharmaceuticals
AVDL
$1.44B
$885K 0.5%
91,413
– –
AXSM icon
30
Axsome Therapeutics
AXSM
$6.2B
$819K 0.46%
+210,000
New +$819K
LUMO
31
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$613K 0.34%
+2,824
New +$613K
PFNX
32
DELISTED
Pfenex Inc.
PFNX
$499K 0.28%
+85,867
New +$499K
OASM
33
DELISTED
Oasmia Pharmaceutical AB
OASM
$377K 0.21%
197,470
+15,200
+8% +$29K
FWP
34
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$306K 0.17%
2,032
-5,289
-72% -$796K
TMBR
35
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$158K 0.09%
21
-55
-72% -$414K
ANTH
36
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$142K 0.08%
+41,714
New +$142K
INSM icon
37
Insmed
INSM
$30B
– –
0
– –
ACAD icon
38
Acadia Pharmaceuticals
ACAD
$4.31B
– –
0
– –
ACRS icon
39
Aclaris Therapeutics
ACRS
$220M
– –
-138,441
Closed -$3.76M
ALNY icon
40
Alnylam Pharmaceuticals
ALNY
$59.7B
– –
0
– –
AMGN icon
41
Amgen
AMGN
$151B
– –
-16,430
Closed -$2.4M
ATNM icon
42
Actinium Pharmaceuticals
ATNM
$52.4M
– –
-54,969
Closed -$1.44M
EW icon
43
Edwards Lifesciences
EW
$47.4B
– –
-165,000
Closed -$5.15M
HUM icon
44
Humana
HUM
$37.4B
– –
0
– –
IQV icon
45
IQVIA
IQV
$30.9B
– –
0
– –
JNJ icon
46
Johnson & Johnson
JNJ
$428B
– –
0
– –
MOH icon
47
Molina Healthcare
MOH
$9.13B
– –
0
– –
MRK icon
48
Merck
MRK
$208B
– –
0
– –
PFE icon
49
Pfizer
PFE
$139B
– –
0
– –
PRGO icon
50
Perrigo
PRGO
$3.19B
– –
-29,329
Closed -$2.44M
1
2
3